What is SRT Therapeutics worth?
$69.0Mlast known valuation
SRT Therapeutics last raised $47.4M in its Early Stage VC (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for SRT Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $47.4M | ▮ | ▮ |
How SRT Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For SRT Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is SRT Therapeutics worth?
- SRT Therapeutics's last known valuation is $69.0M.
- How much has SRT Therapeutics raised?
- SRT Therapeutics has raised $47.4M in total funding across 1 recorded rounds.
- When did SRT Therapeutics last raise?
- SRT Therapeutics last raised in Apr 2025 (Early Stage VC), raising $47.4M.